Sopharma Trading AD (XBUL:SFT) E10: €0.34 (As of Mar. 2026)


XBUL:SFT Sopharma Trading AD XBUL:SFT
85 GF Score
Price €2.92
GF Value €7.63
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Sopharma Trading AD E10?

Sopharma Trading AD XBUL:SFT +0.69% 85 E10 is €0.34 as of Mar. 2026. GuruFocus rates XBUL:SFT with a GF Score™ of 85/100 and a GF Value™ of €7.63 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sopharma Trading AD's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.240. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.34 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Sopharma Trading AD's average E10 Growth Rate was 17.20% per year. During the past 3 years, the average E10 Growth Rate was 21.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Sopharma Trading AD was 21.10% per year. The lowest was 21.10% per year. And the median was 21.10% per year.

As of today (2026-07-05), Sopharma Trading AD's current stock price is €2.92. Sopharma Trading AD's E10 for the quarter that ended in Mar. 2026 was €0.34. Sopharma Trading AD's Shiller PE Ratio of today is 8.59.

During the past 13 years, the highest Shiller PE Ratio of Sopharma Trading AD was 34.44. The lowest was 8.41. And the median was 24.38.


Sopharma Trading AD  (XBUL:SFT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sopharma Trading AD's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=2.92/0.34
=8.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Sopharma Trading AD was 34.44. The lowest was 8.41. And the median was 24.38.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sopharma Trading AD E10 Related Terms


Sopharma Trading AD E10 Historical Data

* Premium members only.

The historical data trend for Sopharma Trading AD's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sopharma Trading AD E10 Chart

Sopharma Trading AD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.18 0.21 0.25 0.32

Sopharma Trading AD Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.31 0.33 0.32 0.34

XBUL:SFT vs MCK, CAH, COR: E10 Comparison

For the Medical Distribution subindustry, Sopharma Trading AD's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma Trading AD Shiller PE Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sopharma Trading AD's Shiller PE Ratio falls into.


XBUL:SFT
85GF Score
Sopharma Trading AD XBUL:SFT
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sopharma Trading AD E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sopharma Trading AD's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.24/330.2130*330.2130
=0.240

Current CPI (Mar. 2026) = 330.2130.

Sopharma Trading AD Quarterly Data

per share eps CPI Adj_EPS
201603 0.056 238.132 0.078
201606 0.031 241.018 0.042
201612 0.000 241.432 0.000
201703 0.051 243.801 0.069
201706 0.027 244.955 0.036
201709 0.031 246.819 0.041
201712 0.030 246.524 0.040
201803 0.030 249.554 0.040
201806 0.029 251.989 0.038
201809 0.036 252.439 0.047
201812 0.036 251.233 0.047
201903 0.036 254.202 0.047
201906 0.028 256.143 0.036
201909 0.025 256.759 0.032
201912 0.041 256.974 0.053
202003 0.061 258.115 0.078
202006 0.018 257.797 0.023
202009 0.020 260.280 0.025
202012 0.066 260.474 0.084
202103 0.066 264.877 0.082
202106 0.024 271.696 0.029
202109 0.066 274.310 0.079
202112 -0.042 278.802 -0.050
202203 0.148 287.504 0.170
202206 0.086 296.311 0.096
202209 0.116 296.808 0.129
202212 -0.219 296.797 -0.244
202303 0.163 301.836 0.178
202306 0.123 305.109 0.133
202309 0.066 307.789 0.071
202312 0.076 306.746 0.082
202403 0.199 312.332 0.210
202406 0.158 314.175 0.166
202409 0.117 315.301 0.123
202412 0.123 315.605 0.129
202503 0.350 319.799 0.361
202506 0.267 322.561 0.273
202509 0.184 324.800 0.187
202512 0.058 324.054 0.059
202603 0.240 330.213 0.240

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.34 mean?
Sopharma Trading AD (XBUL:SFT) has a E10 of €0.34 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sopharma Trading AD and its competitors.
Is Sopharma Trading AD's E10 too high?
Sopharma Trading AD's current E10 is €0.34. Overall, Sopharma Trading AD has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sopharma Trading AD's E10 compare to MCK and CAH?
Sopharma Trading AD's E10 of €0.34 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Distribution company?
A good E10 depends on the Medical Distribution industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sopharma Trading AD and its competitors. Sopharma Trading AD's current E10 is €0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma Trading AD stock overvalued right now?
Based on GuruFocus' analysis, Sopharma Trading AD (XBUL:SFT) is currently considered Significantly Undervalued. The stock's GF Value™ is €7.63, compared to a current price of €2.92 — trading 61.7% below its estimated fair value. The current E10 is €0.34. Sopharma Trading AD's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Sopharma Trading AD (XBUL:SFT), the current E10 is €0.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sopharma Trading AD (XBUL:SFT) Overvalued in 2026?

Based on GuruFocus' analysis, Sopharma Trading AD stock appears to be undervalued. The current stock price of €2.92 is trading 61.7% below its estimated GF Value™ of €7.63. GuruFocus considers Sopharma Trading AD to be Significantly Undervalued.

Key valuation signals for XBUL:SFT:

  • E10: €0.34
  • GF Value™: €7.63 vs. price of €2.92 (61.7% below fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the XBUL:SFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sopharma Trading AD Business Description

Address Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.
85GF Score

Get the complete analysis for XBUL:SFT

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.92
Price
€7.63
GF Value